PATENT CLAIM ANALYSIS

Application Number: 16404441
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["530", "324000"]

Abstract:
The present invention relates to the use of elafin for the treatment and/or prevention of diseases or disorders associated with an increase in troponin levels, which are non elastase dependent. The present invention in a preferred embodiment relates to a method and composition, using elafin, for protecting the heart muscle or other muscles from damage induced by abnormal blood flow and/or inflammation, which may result from, for example, a heart infarction. The present invention additionally or concomitantly relates to the use of elafin for the treatment and/or prevention of disorders or diseases which are associated with a rise in the level of troponin I and/or T.

Claim (Index 8):
The method according to  claim 1 , wherein the polypeptide is for a preventive use and is applied as a coating to an implant and/or stent.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 100.0
- Lexical Diversity: 1.91667
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12350104', '10322839', '10139086', '12665859', '10945442']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.645643773714478
- 35 USC 102 Novelty (BERT): 0.5087090982524004
- Combined Prediction Score: 0.6319503061682702
- Mean Citation Score: 205.619212
- Max Citation Score: 225.04285
- Similarity Product: 130.99908704155683

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test